• Cixutumumab
    Cixutumumab (IMC-A12) is a human monoclonal antibody for the treatment of solid tumors. This drug was developed by ImClone Systems, since acquired by...
    6 KB (617 words) - 14:25, 9 May 2024
  • Thumbnail for Dexamethasone
    Dexamethasone
    BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab Figitumumab Ganitumab Robatumumab R1507 Teprotumumab Xentuzumab...
    68 KB (5,999 words) - 20:41, 31 August 2024
  • Thumbnail for Amitriptyline
    Amitriptyline
    BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab Figitumumab Ganitumab Robatumumab R1507 Teprotumumab Xentuzumab...
    92 KB (8,688 words) - 04:50, 27 September 2024
  • Thumbnail for Erythropoietin
    Erythropoietin
    BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab Figitumumab Ganitumab Robatumumab R1507 Teprotumumab Xentuzumab...
    31 KB (3,430 words) - 05:24, 28 August 2024
  • Thumbnail for Insulin
    Insulin
    BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab Figitumumab Ganitumab Robatumumab R1507 Teprotumumab Xentuzumab...
    121 KB (13,799 words) - 18:31, 13 September 2024
  • List of drugs: Ci
    (INN) citiolone (INN) Citracal Citrihexal (Hexal Australia) [Au], also known as calcitriol Citrotein Citrucel cixutumumab (USAN, INN) cizolirtine (INN)...
    10 KB (469 words) - 03:13, 25 May 2024
  • Thumbnail for Osimertinib
    Osimertinib
    BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab Figitumumab Ganitumab Robatumumab R1507 Teprotumumab Xentuzumab...
    17 KB (1,559 words) - 21:20, 27 September 2024
  • Thumbnail for Dehydroepiandrosterone
    Dehydroepiandrosterone
    BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab Figitumumab Ganitumab Robatumumab R1507 Teprotumumab Xentuzumab...
    42 KB (3,935 words) - 04:01, 30 April 2024
  • Thumbnail for List of therapeutic monoclonal antibodies
    List of therapeutic monoclonal antibodies
    Citatuzumab bogatox Fab humanized EpCAM ovarian cancer and other solid tumors Cixutumumab mab human IGF-1 receptor (CD221) solid tumors Clazakizumab mab humanized...
    136 KB (4,020 words) - 06:13, 27 September 2024
  • Anti-VEGF
    BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab Figitumumab Ganitumab Robatumumab R1507 Teprotumumab Xentuzumab...
    14 KB (1,671 words) - 23:17, 4 September 2024
  • Cerebrolysin
    BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab Figitumumab Ganitumab Robatumumab R1507 Teprotumumab Xentuzumab...
    13 KB (1,177 words) - 02:19, 4 September 2024
  • Thumbnail for Filgrastim
    Filgrastim
    BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab Figitumumab Ganitumab Robatumumab R1507 Teprotumumab Xentuzumab...
    24 KB (1,710 words) - 19:18, 30 August 2024
  • Thumbnail for Nintedanib
    Nintedanib
    BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab Figitumumab Ganitumab Robatumumab R1507 Teprotumumab Xentuzumab...
    34 KB (3,021 words) - 12:39, 5 August 2024
  • Thumbnail for Fruquintinib
    Fruquintinib
    BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab Figitumumab Ganitumab Robatumumab R1507 Teprotumumab Xentuzumab...
    10 KB (579 words) - 06:46, 26 June 2024
  • Neurotrophic factors
    BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab Figitumumab Ganitumab Robatumumab R1507 Teprotumumab Xentuzumab...
    16 KB (1,784 words) - 04:08, 6 January 2024
  • Bevacizumab
    BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab Figitumumab Ganitumab Robatumumab R1507 Teprotumumab Xentuzumab...
    73 KB (6,455 words) - 18:49, 12 September 2024
  • Thumbnail for Fosgonimeton
    Fosgonimeton
    BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab Figitumumab Ganitumab Robatumumab R1507 Teprotumumab Xentuzumab...
    3 KB (111 words) - 22:21, 13 September 2024
  • Thumbnail for Cetuximab
    Cetuximab
    BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab Figitumumab Ganitumab Robatumumab R1507 Teprotumumab Xentuzumab...
    26 KB (2,420 words) - 02:40, 26 September 2024
  • Thumbnail for Dihexa
    Dihexa
    BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab Figitumumab Ganitumab Robatumumab R1507 Teprotumumab Xentuzumab...
    7 KB (492 words) - 07:27, 13 September 2024
  • IGF-1 LR3
    BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab Figitumumab Ganitumab Robatumumab R1507 Teprotumumab Xentuzumab...
    5 KB (412 words) - 23:17, 19 June 2023
  • Thumbnail for Repotrectinib
    Repotrectinib
    BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab Figitumumab Ganitumab Robatumumab R1507 Teprotumumab Xentuzumab...
    10 KB (661 words) - 04:10, 26 June 2024
  • Thumbnail for Neurotrophin
    Neurotrophin
    BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab Figitumumab Ganitumab Robatumumab R1507 Teprotumumab Xentuzumab...
    27 KB (3,078 words) - 18:33, 22 September 2024
  • Thumbnail for Vemurafenib
    Vemurafenib
    BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab Figitumumab Ganitumab Robatumumab R1507 Teprotumumab Xentuzumab...
    21 KB (1,808 words) - 17:43, 7 September 2024
  • Thumbnail for Insulin-like growth factor 1
    Insulin-like growth factor 1
    BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab Figitumumab Ganitumab Robatumumab R1507 Teprotumumab Xentuzumab...
    35 KB (4,573 words) - 09:59, 28 August 2024
  • Thumbnail for Lenvatinib
    Lenvatinib
    BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab Figitumumab Ganitumab Robatumumab R1507 Teprotumumab Xentuzumab...
    11 KB (934 words) - 14:21, 19 September 2024
  • Amivantamab
    BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab Figitumumab Ganitumab Robatumumab R1507 Teprotumumab Xentuzumab...
    24 KB (1,890 words) - 00:34, 21 September 2024
  • Thumbnail for Faricimab
    Faricimab
    BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab Figitumumab Ganitumab Robatumumab R1507 Teprotumumab Xentuzumab...
    20 KB (1,566 words) - 08:58, 12 August 2024
  • Thumbnail for Testosterone
    Testosterone
    BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab Figitumumab Ganitumab Robatumumab R1507 Teprotumumab Xentuzumab...
    149 KB (15,717 words) - 14:45, 15 September 2024
  • Thumbnail for Trametinib
    Trametinib
    BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab Figitumumab Ganitumab Robatumumab R1507 Teprotumumab Xentuzumab...
    15 KB (975 words) - 03:53, 27 June 2024
  • Thumbnail for HER2
    HER2
    BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab Figitumumab Ganitumab Robatumumab R1507 Teprotumumab Xentuzumab...
    43 KB (4,651 words) - 13:41, 27 July 2024